Skip to main content

UBS Group AG

Position in CLLS — Cellectis S.A.

CIK 1610520 ZURICH, V8

Position in CLLS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$101,778
+$7,396 QoQ
Shares Held
33,926
+13.9% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 27 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. CLLS ranks #361 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CLLS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $101,778 33,926
2026-03-31 $94,382 29,774
2025-12-31 $242,482 50,100
2025-09-30 $83,500 29,299
2025-06-30 $39,084 25,629
2025-03-31 $55,149 44,475
2024-12-31 $412,345 229,081
2023-12-31 $308 100
2023-09-30 $6,375 4,035
2023-03-31 $636 330
2022-12-31 $11,438 5,447
2022-09-30 $8,946 3,907
2022-06-30 $1,114 394
2022-03-31 $12,566 2,768
2021-12-31 $82,222 10,126
2021-09-30 $205,568 16,302
2021-06-30 $227,594 14,712
2021-03-31 $1,478,765 73,170
2020-12-31 $1,816,266 67,120
2020-09-30 $1,453,471 78,566
2020-06-30 $350,339 19,682
2020-03-31 $279,863 30,420